Regulation of galectins by hypoxia and their relevance in angiogenesis: Strategies and methods

Methods in Molecular Biology

Volumn 1207, Issue , 2014, Pages 293-304

  Salatino, Mariana ^a   Croci, Diego O ^a   Laderach, Diego J ^a   Compagno, Daniel ^a   Gentilini, Lucas ^a   Dalotto Moreno, Tomas ^a   Dergan Dylon, L Sebastián ^a   Méndez Huergo, Santiago P ^a   Toscano, Marta A ^a   Cerliani, Juan P ^a   Rabinovich, Gabriel A ^a  

^a NONE

Author keywords

Angiogenesis; Galectin; Hypoxia; Tumor neovascularization

Indexed keywords

ECALECTIN; GALECTIN 1; GALECTIN 3; GALECTIN 8; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HIF1A PROTEIN, HUMAN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC THERAPY; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOXIA; MEDICAL DECISION MAKING; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR MICROENVIRONMENT; CELL HYPOXIA; CELL MOTION; CHEMISTRY; CYTOLOGY; METABOLISM; SOLUBILITY; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL HYPOXIA; CELL MOVEMENT; GALECTIN 1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PATHOLOGIC; SOLUBILITY; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84921715675     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1396-1_19     Document Type: Article

References (17)

1. Ferrara N, Alitalo K (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 5:1359–1364
2. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
3. Croci D et al (2012) Disrupting galectin-1 interactions with Nglycans suppresses hypoxia- driven angiogenesis and tumorigenesis in Kaposi’s sarcoma. J Exp Med 209(11):1985–2000
4. Le QT et al (2005) Galectin-1: A link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23:8932–8941
5. Zhao XY, Zhao KW, Jiang Y, Zhao M, Chen GQ (2011) Synergistic induction of galectin-1 by CCAAT/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells. J Biol Chem 286:36808–36819
6. Thijssen VL et al (2010) Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 70:6216–6224
7. Thijssen VL et al (2006) Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy. Proc Natl Acad Sci U S A 103:15975–15980
8. Hsieh SH et al (2008) Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene 27:3746–3753
9. Mathieu V et al (2012) Galectin-1 in melanoma biology and related neo-angiogenesis processes. J Invest Dermatol 132:2245–2254
10. Laderach DJ et al (2013) A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease. Cancer Res 73:86–96
11. Markowska AI, Liu FT, Panjwani N (2010) Galectin-3 is an important mediator of VEGFand bFGF-mediated angiogenic response. J Exp Med 207:1981–1993
12. Markowska AI, Jefferies KC, Panjwani N (2011) Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem 286:29913–29921
13. Nangia-Makker P, Balan V, Raz A (2008) Regulation of tumor progression by extracellular galectin-3. Cancer Microenviron 1:43–51
14. Delgado VM et al (2011) Modulation of endothelial cell migration and angiogenesis: a novel function for the “tandem-repeat” lectin galectin- 8. FASEB J 25:242–254
15. Croci DO et al. (2014) Glycosylation-dependent lectin-receptor interactions preserve angiogenesisin anti-VEGF refractory tumors. Cell 156: 744–58
16. Croci DO et al (2011) Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed. PLoS ONE 6:172-183
17. Toscano MA et al (2007) Dissecting the pathophysiologic role of endogenous lectins: glycan- binding proteins with cytokine-like activity? Cytokine Growth Factor Rev 18: 57–71